Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001359620-21-000005
Filing Date
2021-12-22
Accepted
2021-12-22 15:16:16
Documents
1
Effectiveness Date
2021-12-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9750
  Complete submission text file 0001359620-21-000005.txt   10967
Mailing Address 387 TECHNOLOGY CIR. NW SUITE 125 ATLANTA GA 30313
Business Address 387 TECHNOLOGY CIR. NW SUITE 125 ATLANTA GA 30313 678-862-7729
Vero Biotech Inc. (Filer) CIK: 0001359620 (see all company filings)

EIN.: 204604159 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-426342 | Film No.: 211512943
SIC: 2834 Pharmaceutical Preparations